I’ve given a lot of thought about whether to drop testosterone supplementation. For a number of reasons, I’ve decided to continue. But as I learned more about it, I uncovered an unexpected red flag; not for me, but for our female readers.
For while there seems to be substantive evidence supporting my doctors’ decision to start me on testosterone therapy–including helping improve bone density and muscle strength–the news isn’t as good for female myeloma patients that are currently using hormone therapy following menopause.
Check-out IMF Hotline Coordinator, Debbie Birns, cautionary email. I’ve used highlighted the key sentences in BOLD:
Just want to make sure that you understood that in that admittedly ancient article I sent you, there were no androgen receptors (“AR”–testosterone is an androgen) on 13 myeloma cells lines, but there were progesterone and estrogen receptors (ER and PR) on the cell lines tested. We do tell female patients not to use hormone replacement therapy, but there is no medical data that I could find to indicate that testosterone “feeds” myeloma. It will be interesting to see what kind of comments your blog generates.
Debbie Birns, Hotline Coordinator
International Myeloma Foundation
12650 Riverside Drive, Ste. 206
North Hollywood, CA 91607
Good to know! Ladies, check with your doctors if you have continued with hormone replacement therapy after you were diagnosed.
As a side note, Debbie and I will get a chance to talk shop at ASH in New Orleans this December. I’m looking forward to it. Thanks for your input, Debbie!
Feel good and keep smiling! Pat